Literature DB >> 9207082

Prion protein NMR structure and species barrier for prion diseases.

M Billeter1, R Riek, G Wider, S Hornemann, R Glockshuber, K Wüthrich.   

Abstract

The structural basis of species specificity of transmissible spongiform encephalopathies, such as bovine spongiform encephalopathy or "mad cow disease" and Creutzfeldt-Jakob disease in humans, has been investigated using the refined NMR structure of the C-terminal domain of the mouse prion protein with residues 121-231. A database search for mammalian prion proteins yielded 23 different sequences for the fragment 124-226, which display a high degree of sequence identity and show relevant amino acid substitutions in only 18 of the 103 positions. Except for a unique isolated negative surface charge in the bovine protein, the amino acid differences are clustered in three distinct regions of the three-dimensional structure of the cellular form of the prion protein. Two of these regions represent potential species-dependent surface recognition sites for protein-protein interactions, which have independently been implicated from in vitro and in vivo studies of prion protein transformation. The third region consists of a cluster of interior hydrophobic side chains that may affect prion protein transformation at later stages, after initial conformational changes in the cellular protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207082      PMCID: PMC23812          DOI: 10.1073/pnas.94.14.7281

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  16 in total

1.  Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.

Authors:  S Hornemann; R Glockshuber
Journal:  J Mol Biol       Date:  1996-09-06       Impact factor: 5.469

2.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD.

Authors:  J Collinge; K C Sidle; J Meads; J Ironside; A F Hill
Journal:  Nature       Date:  1996-10-24       Impact factor: 49.962

3.  Self-replication and scrapie.

Authors:  J S Griffith
Journal:  Nature       Date:  1967-09-02       Impact factor: 49.962

Review 4.  Molecular biology of prion diseases.

Authors:  S B Prusiner
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

5.  Comparison of conformational characteristics in structurally similar protein pairs.

Authors:  T P Flores; C A Orengo; D S Moss; J M Thornton
Journal:  Protein Sci       Date:  1993-11       Impact factor: 6.725

Review 6.  Molecular biology and pathogenesis of prion diseases.

Authors:  S B Prusiner
Journal:  Trends Biochem Sci       Date:  1996-12       Impact factor: 13.807

7.  Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein.

Authors:  G C Telling; M Scott; J Mastrianni; R Gabizon; M Torchia; F E Cohen; S J DeArmond; S B Prusiner
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

8.  Prion protein gene variation among primates.

Authors:  H M Schätzl; M Da Costa; L Taylor; F E Cohen; S B Prusiner
Journal:  J Mol Biol       Date:  1995-01-27       Impact factor: 5.469

9.  Species specificity in the cell-free conversion of prion protein to protease-resistant forms: a model for the scrapie species barrier.

Authors:  D A Kocisko; S A Priola; G J Raymond; B Chesebro; P T Lansbury; B Caughey
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  Novel proteinaceous infectious particles cause scrapie.

Authors:  S B Prusiner
Journal:  Science       Date:  1982-04-09       Impact factor: 47.728

View more
  39 in total

1.  Specific binding of normal prion protein to the scrapie form via a localized domain initiates its conversion to the protease-resistant state.

Authors:  M Horiuchi; B Caughey
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

2.  Normal prion protein has an activity like that of superoxide dismutase.

Authors:  D R Brown; B S Wong; F Hafiz; C Clive; S J Haswell; I M Jones
Journal:  Biochem J       Date:  1999-11-15       Impact factor: 3.857

3.  Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155.

Authors:  S A Priola; J Chabry; K Chan
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

4.  Structure of the β2-α2 loop and interspecies prion transmission.

Authors:  Cyrus Bett; Natalia Fernández-Borges; Timothy D Kurt; Melanie Lucero; K Peter R Nilsson; Joaquín Castilla; Christina J Sigurdson
Journal:  FASEB J       Date:  2012-04-09       Impact factor: 5.191

5.  Possible role of region 152-156 in the structural duality of a peptide fragment from sheep prion protein.

Authors:  Simon Megy; Gildas Bertho; Sergey A Kozin; Pascale Debey; Gaston Hui Bon Hoa; Jean-Pierre Girault
Journal:  Protein Sci       Date:  2004-11-10       Impact factor: 6.725

Review 6.  A structural overview of the vertebrate prion proteins.

Authors:  Annalisa Pastore; Adriana Zagari
Journal:  Prion       Date:  2007-07-08       Impact factor: 3.931

7.  Helices 2 and 3 are the initiation sites in the PrP(C) → PrP(SC) transition.

Authors:  Jie Chen; D Thirumalai
Journal:  Biochemistry       Date:  2012-12-31       Impact factor: 3.162

8.  Refinement of under-determined loops of Human Prion Protein by database-derived distance constraints.

Authors:  Feng Cui; Kriti Mukhopadhyay; Won-Bin Young; Robert L Jernigan; Zhijun Wu
Journal:  Int J Data Min Bioinform       Date:  2009       Impact factor: 0.667

9.  Exploring the propensities of helices in PrP(C) to form beta sheet using NMR structures and sequence alignments.

Authors:  R I Dima; D Thirumalai
Journal:  Biophys J       Date:  2002-09       Impact factor: 4.033

10.  Identifying key components of the PrPC-PrPSc replicative interface.

Authors:  Gil C Abalos; Justin T Cruite; Anne Bellon; Saskia Hemmers; Junya Akagi; James A Mastrianni; R Anthony Williamson; Laura Solforosi
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.